期刊文献+

L-精氨酸抑制非对称性二甲基精氨酸对内皮祖细胞的增殖作用 被引量:6

Depressant Effects of Asymmetric Dimethylarginine on the Proliferation of Endothelial Progenitor Cell and the Antagonism of L-Arginine
下载PDF
导出
摘要 目的研究非对称性二甲基精氨酸对人脐带血内皮祖细胞增殖的影响及观测L-精氨酸对非对称性二甲基精氨酸的抑制作用。方法从脐带血中分离出单个核细胞,体外培养7天,在贴壁细胞中加入不同浓度的非对称性二甲基精氨酸(1、5和10μmol/L)作用不同时间(24、48和72h),用MTT比色法和细胞克隆计数法评价非对称性二甲基精氨酸对内皮祖细胞增殖的影响;加入L-精氨酸后采用MTT比色法和高倍荧光显微镜下DiI标记的乙酰化低密度脂蛋白染色细胞计数法分析L-精氨酸对非对称性二甲基精氨酸作用内皮祖细胞的影响;硝酸还原酶法测定培养基上清液一氧化氮含量,采用化学比色法测定培养基上清液总一氧化氮合酶活力。结果非对称性二甲基精氨酸呈量效和时效性地减少内皮祖细胞数目和增殖能力;随着L-精氨酸浓度的增加,L-精氨酸能有效抑制非对称性二甲基精氨酸对内皮祖细胞的作用。结论非对称性二甲基精氨酸可能通过抑制内皮祖细胞的增殖促进内皮功能不全的发展,而外源性L-精氨酸能抑制非对称性二甲基精氨酸的作用。 Aim To investigate the effects of asymmetric dimethylarginine (ADMA) on the proliferation of endothelial progenitor cell (EPC) of human umbilical cord blood and observe whether L-arginine can antagonize the effects of ADMA. Methods Mononuclear cells were isolated from fresh cord blood and cultured for 7days, attached cells were incubated with different concentration of ADMA ( 1, 5 and 10 μmol/L) among different times (24, 48 and 72 h). MTT assay was used and colony forming units (CFU) were quantified to evaluate the proliferation of EPC after treated with ADMA. Meanwhile, MTr assay was used and DiⅠ-acLDL uptake cells under high-power field of fluorescence microscopy were quantified to assay effects of L-arginine on ADMA-induced EPC proliferation. Nitric oxide (NO) and nitric oxide synthase (NOS) in the supematant were measured by nitrate reductase assay and chemical colorimetry assay. Results Incubation of EPC with ADMA dose and time-dependently decreased the number and the proliferation of EPC. In addition, the depressant effect of ADMA on EPC were dismissed with the inceasing dosage of L-arginine. Conclusions It is suggested that ADMA can promote endothelial dysfunction by means of depressant EPC proliferation and exogeno L-arginine maybe antagonize the effects of ADMA.
出处 《中国动脉硬化杂志》 CAS CSCD 2007年第10期751-754,共4页 Chinese Journal of Arteriosclerosis
关键词 内科学 非对称性二甲基精氨酸 L-精氨酸 内皮祖细胞 细胞增殖 Asymmetric Dimethylarginine L-Arginine Endothelial Progenitor Cells Cell Proliferation
  • 相关文献

参考文献12

  • 1姜德建,李元建.非对称性二甲基精氨酸——新的心血管疾病危险因子和药物防治靶点[J].中国动脉硬化杂志,2005,13(3):379-382. 被引量:19
  • 2Boger RH,Bode-Boger SM,Sydow K,Heistad DD,Lentz SR.Plasma concentration of asymmetric dimethylarginine,an endogenous inhibitor of nitric oxide synthase,is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia[J].Arteriascler Thromb Vasc Biol.2000.20(12):1557-564.
  • 3Hill JM,Zalos G,Halcox JP,Schenke WH,Waclawiw MA,Quyyumi AA,et al.Circulating endothelial progeni tor cells.vascular function ,and cardio vascular risk[J].N Engl J Med.2003.348(7):593.
  • 4Walter DH,Rittig K,Bahlmann F H,Statin therapy accelerate reendothelialization[J].Circulation.2002.105(25):3017.
  • 5Thum T,Tsikas D,Stein S,Schultheiss M.Eigenthaler M,Anker SD,et al.Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine[J].J Am Coll Cardiol.2005.46(9):1693-701.
  • 6Vasa M,Fichtlscherer S,Aicher A,Adler K,Urbich C,Martin H,et al.Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease[J].Circ Res.2001.89(1):E1-7.
  • 7熊燕,李元建.内源性一氧化氮合酶抑制物:一种新的内皮功能不全预测因子[J].中国药理学与毒理学杂志,2000,14(3):161-166. 被引量:16
  • 8Boger RH,Bode-Boger SM,Tsao PS,Lin PS,Chan JR,Cooke JP.An endogenous inhititor of nitrc oxide synthase regulates endothelial adhesiveness for monocytes[J].J Am Coll.2000.36(7):2287-295.
  • 9Carmen U,Stefanie D.Endothelial progenitor cells:Characterization and role in vascular biology[J].Circ Res.2004.95:343-353.
  • 10Aicher A,Heeschen C,Mildner Rihm C.Easential role of endothelial nitric oxide synthase for mobilization of stem and pregenitor cells[J].Nat Med.2003.9:1370-376.

二级参考文献37

  • 1熊燕,李元建,余先杰,刘桂珍,李年生.高胆固醇血症家兔NO合成酶抑制物含量与脂质过氧化的关系(英文)[J].中国药理学报,1996,17(2):149-152. 被引量:2
  • 2Feng Q,Cardiovasc Res,1998年,37卷,3期,667页
  • 3Yu X J,Life Sci,1994年,54卷,12期,753页
  • 4Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol, 2000, 20(9): 2032-037.
  • 5Boger RH, Bode-Boger SM, Tsao PS, Lin PS, Chan JR, Cooke JP. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol, 2000, 36(7): 2287-295.
  • 6Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP. Novel mechamism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circularion, 1999, 99(24): 3092-095.
  • 7Chan JR, Boger RH, Bode-Boger SM, Tangphao O, Tsao PS, Blaschke TF, et al. Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol, 2000, 20(4): 1040-046.
  • 8Boger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. cardiovasc Res, 2003, 59(4): 824-833.
  • 9Lu TM, Ding YA, Lin SJ, Lee WS, Tai HC. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J, 2003, 24(21): 1912-919.
  • 10Nijveldt RJ, Teerlink T, Siroen MP, van Lambalgen AA, Rauwerda JA, van Leeuwen PA. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr, 2003, 22(1): 17-22.

共引文献33

同被引文献69

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部